Oliver is an experienced chemist with a long standing list of achievements in the field of drug delivery technologies, including the supervision of several CMC campaigns with liposomal-based nucleic acid inhibitors at Silence Therapeutics. His work opened the path to 2 clinical studies. Prior to Silence Therapeutics Oliver was instrumental in formulation work at G.O.T. Therapeutics focusing on liposomal-based drug-delivery systems for cytostatics and nucleic acids. Oliver received his Ph.D. at the University of Wuppertal.